Gene-gene interactions in APOL1-associated nephropathy

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 587-594

  Divers, Jasmin ^a   Palmer, Nicholette D ^a   Lu, Lingyi ^a   Langefeld, Carl D ^a   Rocco, Michael V ^a   Hicks, Pamela J ^a   Murea, Mariana ^a   Ma, Lijun ^a   Bowden, Donald W ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African American; APOL1; Bone morphogenetic protein 4 (BMP4); Kidney disease; Podocin (NPHS2); Serologically defined colon cancer antigen 8 (SDCCAG8)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; PODOCIN; APOL1 PROTEIN, HUMAN; APOLIPOPROTEIN; AUTOANTIGEN; BMP4 PROTEIN, HUMAN; HIGH DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; SDCCAG8 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR PROTEIN;

ADULT; AFRICAN AMERICAN; ALBUMINURIA; APOLIPOPROTEIN L1 GENE; ARTICLE; BMP4 GENE; CONTROLLED STUDY; ECTO NOX DISULFIDE THIOL EXCHANGER 1 GENE; END STAGE RENAL DISEASE; FEMALE; FIRST DEGREE RELATIVE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGICALLY DEFINED COLON CANCER ANTIGEN 8 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STANNIOCALCIN 1 GENE; TRIB1 GENE; AGED; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; EPISTASIS; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GLOMERULONEPHRITIS; MIDDLE AGED; PATHOPHYSIOLOGY; RISK;

ADULT; AFRICAN AMERICANS; AGED; APOLIPOPROTEINS; AUTOANTIGENS; BONE MORPHOGENETIC PROTEIN 4; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, HDL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84895737153     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft423     Document Type: Article

References (39)

1. Divers J, Nunez M, High KP et al. JC Polyoma virus interactions with APOL1 in African Americans with non-diabetic nephropathy. Kidney Int 2013; doi:10.1038/ki.2013.173
2. Skorecki KL, Wasser WG. Hypertension-misattributed kidney disease in African Americans. Kidney Int 2013; 83: 6-9
3. Freedman BI, Bowden DW, Rich SS. Genetic basis of kidney disease. In: Taal MW (ed). Brenner & Rector's The Kidney. Philadelphia: Elsevier Saunders, 2012, pp. 1554-1569
4. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845
5. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350
6. Freedman BI, Kopp JB, Langefeld CD et al. The apolipoprotein L1 (APOL1) Gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010; 21: 1422-1426
7. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137
8. Bostrom MA, Kao WH, Li M et al. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis 2012; 59: 210-221
9. Ko WY, Rajan P, Gomez F et al. Identifying Darwinian selection acting on different human apol1 variants among diverse African populations. Am J Hum Genet 2013; 93: 54-66
10. Tayo BO, Kramer H, Salako BL et al. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. Int Urol Nephrol 2013; 45: 485-494
11. Freedman BI, Langefeld CD, Turner J et al. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int 2012; 82: 805-811
12. Tang H, Peng J,Wang P et al. Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol 2005; 28: 289-301
13. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
14. Box GEP, Cox DR. An analysis of tranformations. J R Statis Soc B 1964; 26: 211-246
15. Manichaikul A, Chen WM, Williams K et al. Analysis of family- and population-based samples in cohort genome-wide association studies. Hum Genet 2012; 131: 275-287
16. Agresti A. An Introduction to Categorical Data Analysis. Hoboken, NJ: JohnWiley & Sons, Inc., 2007
17. Kottgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717
18. Ashley-Koch AE, Okocha EC, Garrett ME et al. MYH9 And APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 2011; 155: 386-394
19. Larsen CP, Beggs ML, Saeed M et al. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol 2013; 24: 722-725
20. U.S. Renal Data System. USRDS 2012 Annual Data Report, Vol 1: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012. Ref Type: Generic
21. Roselli S, Gribouval O, Boute N et al. Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 2002; 160: 131-139
22. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349-354
23. Karle SM, Uetz B, Ronner V et al. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002; 13: 388-393
24. Frishberg Y, Rinat C, Megged O et al. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol 2002; 13: 400-405
25. Caridi G, Bertelli R, Scolari F et al. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 2003; 64: 365
26. Caridi G, Berdeli A, Dagnino M et al. Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin. Am J Kidney Dis 2004; 43: 727-732
27. Pereira AC, Pereira AB, Mota GF et al. NPHS2 R229q functional variant is associated with microalbuminuria in the general population. Kidney Int 2004; 65: 1026-1030
28. Schwarz K, Simons M, Reiser J et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108: 1621-1629
29. Sellin L, Huber TB, Gerke P et al. NEPH1 defines a novel family of podocin interacting proteins. FASEB J 2003; 17: 115-117
30. Huber TB, Kottgen M, Schilling B et al. Interaction with podocin facilitates nephrin signaling. J Biol Chem 2001; 276: 41543-41546
31. Dusel JA, Burdon KP, Hicks PJ et al. Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int 2005; 68: 256-262
32. Otto EA, Hurd TW, Airik R et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet 2010; 42: 840-850
33. Billingsley G, Vincent A, Deveault C et al. Mutational analysis of SDCCAG8 in Bardet-Biedl syndrome patients with renal involvement and absent polydactyly. Ophthalmic Genet 2012; 33: 150-154
34. Martini S, Nair V, Patel SR et al. From SNP to transcriptional mechanism: a model for FRMD3 in diabetic nephropathy. Diabetes 2013; 62: 2605-2612
35. Palmer ND, Freedman BI. Diabetic nephropathy: FRMD3 in diabetic nephropathy- guilt by association. Nat Rev Nephrol 2013; 9: 313-314
36. Friedman DJ, Kozlitina J, Genovese G et al. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011; 22: 2098-2105
37. Ueda H, Miyazaki Y, Matsusaka T et al. Bmp in podocytes is essential for normal glomerular capillary formation. J Am Soc Nephrol 2008; 19: 685-694
38. Madhavan SM, O'Toole JF, Konieczkowski M et al. APOL1 Localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol 2011; 22: 2119-2128
39. Divers J, Vaughan LK, Padilla MA et al. Correcting for measurement error in individual ancestry estimates in structured association tests. Genetics 2007; 176: 1823-1833